40-F Filing

QUIPT HOME MEDICAL CORP. CIK: 1540013 FY 2021

Filing Information

Form Type	40-F
Accession Number	`0001558370-22-000528`
Period End Date	20210930
Filing Date	20220127
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	qipt-20210930x40f_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 56 Cash Flow Statement 69 Stockholders Equity 20

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalents`	$29.23M	USD	Point-in-time
Cash	`CashAndCashEquivalents`	$9.71M	USD	Point-in-time
Cash	`CashAndCashEquivalents`	$34.61M	USD	Point-in-time
Accounts receivable, net	`CurrentTradeReceivables`	$11.94M	USD	Point-in-time
Accounts receivable, net	`CurrentTradeReceivables`	$9.09M	USD	Point-in-time
Accounts receivable, net	`CurrentTradeReceivables`	$9.36M	USD	Point-in-time
Inventory	`Inventories`	$3.58M	USD	Point-in-time
Inventory	`Inventories`	$6.42M	USD	Point-in-time
Inventory	`Inventories`	$9.25M	USD	Point-in-time
Prepaid and other current assets	`CurrentPrepaymentsAndOtherCurrentAssets`	$1.43M	USD	Point-in-time
Prepaid and other current assets	`CurrentPrepaymentsAndOtherCurrentAssets`	$552.00K	USD	Point-in-time
Prepaid and other current assets	`CurrentPrepaymentsAndOtherCurrentAssets`	$604.00K	USD	Point-in-time
Total current assets	`CurrentAssets`	$45.28M	USD	Point-in-time
Total current assets	`CurrentAssets`	$57.23M	USD	Point-in-time
Total current assets	`CurrentAssets`	$23.25M	USD	Point-in-time
Property, equipment, and right of use assets, net	`PropertyPlantAndEquipment`	$14.72M	USD	Point-in-time
Property, equipment, and right of use assets, net	`PropertyPlantAndEquipment`	$16.67M	USD	Point-in-time
Property, equipment, and right of use assets, net	`PropertyPlantAndEquipment`	$23.51M	USD	Point-in-time
Goodwill	`Goodwill`	$1.42M	USD	Point-in-time
Goodwill	`Goodwill`	$3.90M	USD	Point-in-time
Goodwill	`Goodwill`	$12.46M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsOtherThanGoodwill`	$2.20M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsOtherThanGoodwill`	$14.87M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsOtherThanGoodwill`	$5.58M	USD	Point-in-time
Deferred financing costs	`DeferredFinancingCosts`	$416.00K	USD	Point-in-time
Deferred financing costs	`DeferredFinancingCosts`	$556.00K	USD	Point-in-time
Deposits	`LongtermDeposits`	$88.00K	USD	Point-in-time
Deposits	`LongtermDeposits`	$71.00K	USD	Point-in-time
Deposits	`LongtermDeposits`	$85.00K	USD	Point-in-time
Total long-term assets	`NoncurrentAssets`	$26.78M	USD	Point-in-time
Total long-term assets	`NoncurrentAssets`	$18.41M	USD	Point-in-time
Total long-term assets	`NoncurrentAssets`	$51.34M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$108.57M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$41.66M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$72.06M	USD	Point-in-time
Accounts payable	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$6.13M	USD	Point-in-time
Accounts payable	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$7.43M	USD	Point-in-time
Accounts payable	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$9.84M	USD	Point-in-time
Accrued liabilities	`AccrualsClassifiedAsCurrent`	$3.20M	USD	Point-in-time
Accrued liabilities	`AccrualsClassifiedAsCurrent`	$3.49M	USD	Point-in-time
Accrued liabilities	`AccrualsClassifiedAsCurrent`	$1.75M	USD	Point-in-time
Current portion of equipment loans	`CurrentPortionOfLongtermBorrowings`	$6.18M	USD	Point-in-time
Current portion of equipment loans	`CurrentPortionOfLongtermBorrowings`	$4.31M	USD	Point-in-time
Current portion of equipment loans	`CurrentPortionOfLongtermBorrowings`	$6.99M	USD	Point-in-time
Current portion of leases	`CurrentLeaseLiabilities`	$2.04M	USD	Point-in-time
Current portion of leases	`CurrentLeaseLiabilities`	$421.00K	USD	Point-in-time
Current portion of leases	`CurrentLeaseLiabilities`	$2.98M	USD	Point-in-time
Government grant	`CurrentGovernmentGrants`	$4.88M	USD	Point-in-time
Government grant	`CurrentGovernmentGrants`	$2.60M	USD	Point-in-time
Deferred revenue	`AccrualsAndDeferredIncomeIncludingContractLiabilities`	$2.45M	USD	Point-in-time
Deferred revenue	`AccrualsAndDeferredIncomeIncludingContractLiabilities`	$1.80M	USD	Point-in-time
Deferred revenue	`AccrualsAndDeferredIncomeIncludingContractLiabilities`	$1.44M	USD	Point-in-time
Purchase price payable	`ContingentLiabilitiesRecognisedInBusinessCombinationCurrent`	$2.38M	USD	Point-in-time
Purchase price payable	`ContingentLiabilitiesRecognisedInBusinessCombinationCurrent`	$857.00K	USD	Point-in-time
Derivative warrant liability	`CurrentDerivativeFinancialLiabilities`	$1.85M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$15.92M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$32.74M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$24.39M	USD	Point-in-time
Debentures	`NotesAndDebenturesIssued`	$10.55M	USD	Point-in-time
Debentures	`NotesAndDebenturesIssued`	$11.78M	USD	Point-in-time
Debentures	`NotesAndDebenturesIssued`	$12.93M	USD	Point-in-time
Equipment loans	`LongtermBorrowings`	$439.00K	USD	Point-in-time
Equipment loans	`LongtermBorrowings`	$392.00K	USD	Point-in-time
Equipment loans	`LongtermBorrowings`	$1.13M	USD	Point-in-time
Lease liabilities	`NoncurrentLeaseLiabilities`	$3.23M	USD	Point-in-time
Lease liabilities	`NoncurrentLeaseLiabilities`	$1.04M	USD	Point-in-time
Lease liabilities	`NoncurrentLeaseLiabilities`	$4.78M	USD	Point-in-time
Government grant	`NoncurrentGovernmentGrants`	$2.29M	USD	Point-in-time
SBA Loan	`SmallBusinessAdministrationLoanNonCurrent`	$121.00K	USD	Point-in-time
Long-term purchase price payable	`ContingentLiabilitiesRecognisedInBusinessCombinationNonCurrent`	$560.00K	USD	Point-in-time
Long-term purchase price payable	`ContingentLiabilitiesRecognisedInBusinessCombinationNonCurrent`	$133.00K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$28.64M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$49.95M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$43.83M	USD	Point-in-time
Capital stock	`IssuedCapital`	$171.41M	USD	Point-in-time
Capital stock	`IssuedCapital`	$202.83M	USD	Point-in-time
Capital stock	`IssuedCapital`	$151.96M	USD	Point-in-time
Contributed surplus	`CapitalReserve`	$16.18M	USD	Point-in-time
Contributed surplus	`CapitalReserve`	$16.52M	USD	Point-in-time
Contributed surplus	`CapitalReserve`	$21.00M	USD	Point-in-time
Shares to be issued	`SharesToBeIssued`	$657.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-159.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-155.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-165.86M	USD	Point-in-time
TOTAL SHAREHOLDERS' EQUITY	`Equity`	$58.62M	USD	Point-in-time
TOTAL SHAREHOLDERS' EQUITY	`Equity`	$13.02M	USD	Point-in-time
TOTAL SHAREHOLDERS' EQUITY	`Equity`	$28.23M	USD	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	$72.06M	USD	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	$108.57M	USD	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	$41.66M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Rentals of medical equipment	`RentalIncome`	$41.25M	USD	Annual
Rentals of medical equipment	`RentalIncome`	$55.34M	USD	Annual
Sales of medical equipment and supplies	`RevenueFromSaleOfGoods`	$31.39M	USD	Annual
Sales of medical equipment and supplies	`RevenueFromSaleOfGoods`	$47.01M	USD	Annual
Total revenues	`Revenue`	$102.35M	USD	Annual
Total revenues	`Revenue`	$72.64M	USD	Annual
Inventory sold	`RawMaterialsAndConsumablesUsed`	$28.17M	USD	Annual
Inventory sold	`RawMaterialsAndConsumablesUsed`	$19.93M	USD	Annual
Operating expenses	`OperatingExpense`	$52.76M	USD	Annual
Operating expenses	`OperatingExpense`	$38.63M	USD	Annual
Depreciation	`DepreciationExpense`	$13.86M	USD	Annual
Depreciation	`DepreciationExpense`	$16.21M	USD	Annual
Amortization of intangible assets	`AmortisationExpense`	$1.57M	USD	Annual
Amortization of intangible assets	`AmortisationExpense`	$678.00K	USD	Annual
Stock-based compensation	`ExpenseFromSharebasedPaymentTransactionsWithEmployees`	$171.00K	USD	Annual
Stock-based compensation	`ExpenseFromSharebasedPaymentTransactionsWithEmployees`	$4.95M	USD	Annual
Acquisition-related costs	`AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination`	$89.00K	USD	Annual
Acquisition-related costs	`AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination`	$233.00K	USD	Annual
Gain on sale of property and equipment	`GainsOnDisposalsOfPropertyPlantAndEquipment`	$94.00K	USD	Annual
Gain on sale of property and equipment	`GainsOnDisposalsOfPropertyPlantAndEquipment`	$74.00K	USD	Annual
Other income	`OtherOperatingIncomeExpense`	$1.30M	USD	Annual
Operating income (loss) from continuing operations	`ProfitLossFromOperatingActivities`	$658.00K	USD	Annual
Operating income (loss) from continuing operations	`ProfitLossFromOperatingActivities`	$-1.46M	USD	Annual
Interest expense on convertible debenture	`InterestExpenseOnDebtInstrumentsIssued`	$838.00K	USD	Annual
Interest expense on convertible debenture	`InterestExpenseOnDebtInstrumentsIssued`	$887.00K	USD	Annual
Interest expense on leases	`InterestExpenseOnLeaseLiabilities`	$551.00K	USD	Annual
Interest expense on leases	`InterestExpenseOnLeaseLiabilities`	$461.00K	USD	Annual
Interest expense on loans	`InterestExpenseOnBankLoansAndOverdrafts`	$376.00K	USD	Annual
Interest expense on loans	`InterestExpenseOnBankLoansAndOverdrafts`	$489.00K	USD	Annual
Amortization of financing costs	`IfrsAmortizationOfDebtIssuanceCosts`	$140.00K	USD	Annual
Amortization of financing costs	`IfrsAmortizationOfDebtIssuanceCosts`	$5.00K	USD	Annual
Other interest expense, net	`InterestRevenueExpense`	$-88.00K	USD	Annual
Loss (gain) on foreign currency transactions	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$-173.00K	USD	Annual
Loss (gain) on foreign currency transactions	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$454.00K	USD	Annual
Transaction costs on issuance of financial liabilities	`TransactionCostsOnIssuanceOfFinancialLiabilities`	$210.00K	USD	Annual
Change in fair value of warrants	`GainsLossesOnChangeInFairValueOfWarrants`	$-198.00K	USD	Annual
Change in fair value of warrants	`GainsLossesOnChangeInFairValueOfWarrants`	$-2.11M	USD	Annual
Change in fair value of debentures	`GainsLossesOnChangeInFairValueOfDebentures`	$-3.59M	USD	Annual
Change in fair value of debentures	`GainsLossesOnChangeInFairValueOfDebentures`	$-2.44M	USD	Annual
Loss before taxes from continuing operations	`ProfitLossBeforeTax`	$-9.33M	USD	Annual
Loss before taxes from continuing operations	`ProfitLossBeforeTax`	$-3.58M	USD	Annual
Provision for (recovery of) income taxes	`IncomeTaxExpenseContinuingOperations`	$128.00K	USD	Annual
Provision for (recovery of) income taxes	`IncomeTaxExpenseContinuingOperations`	$-3.15M	USD	Annual
Net loss from continuing operations	`ProfitLossFromContinuingOperations`	$-3.70M	USD	Annual
Net loss from continuing operations	`ProfitLossFromContinuingOperations`	$-6.17M	USD	Annual
Income (loss) from discontinued operations	`ProfitLossFromDiscontinuedOperations`	$-869.00K	USD	Annual
Net loss	`ProfitLoss`	$-6.17M	USD	Annual
Net loss	`ProfitLoss`	$-4.57M	USD	Annual
Basic earnings per share	`BasicEarningsLossPerShare`	$-0.20	USD	Annual
Basic earnings per share	`BasicEarningsLossPerShare`	$-0.20	USD	Annual
Diluted earnings per share	`DilutedEarningsLossPerShare`	$-0.20	USD	Annual
Diluted earnings per share	`DilutedEarningsLossPerShare`	$-0.20	USD	Annual
Basic	`WeightedAverageShares`	22.72M	shares	Annual
Basic	`WeightedAverageShares`	30.44M	shares	Annual
Diluted	`AdjustedWeightedAverageShares`	30.44M	shares	Annual
Diluted	`AdjustedWeightedAverageShares`	22.72M	shares	Annual

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Loss from continuing operations	`ProfitLossFromContinuingOperations`	$-3.70M	USD	Annual
Loss from continuing operations	`ProfitLossFromContinuingOperations`	$-6.17M	USD	Annual
Loss from discontinued operations	`ProfitLossFromDiscontinuedOperations`	$-869.00K	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$17.79M	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$14.54M	USD	Annual
Amortization of financing costs	`AdjustmentsForFinanceCosts`	$5.00K	USD	Annual
Amortization of financing costs	`AdjustmentsForFinanceCosts`	$140.00K	USD	Annual
Accretion of purchase price payable	`AdjustmentsForAccretionOfPurchasePricePayable`	$38.00K	USD	Annual
Interest expense on leases and loans	`AdjustmentsForInterestExpense`	$932.00K	USD	Annual
Interest expense on leases and loans	`AdjustmentsForInterestExpense`	$950.00K	USD	Annual
Loss (gain) on foreign currency transactions	`AdjustmentsForUnrealisedForeignExchangeLossesGains`	$-454.00K	USD	Annual
Loss (gain) on foreign currency transactions	`AdjustmentsForUnrealisedForeignExchangeLossesGains`	$173.00K	USD	Annual
Loss on fair value of warrants	`AdjustmentsForGainsLossesOnChangeInFairValueOfWarrants`	$198.00K	USD	Annual
Loss on fair value of warrants	`AdjustmentsForGainsLossesOnChangeInFairValueOfWarrants`	$2.11M	USD	Annual
Loss on fair value of convertible debentures	`AdjustmentsForGainsLossesOnChangeInFairValueOfConvertibleDebentures`	$2.44M	USD	Annual
Loss on fair value of convertible debentures	`AdjustmentsForGainsLossesOnChangeInFairValueOfConvertibleDebentures`	$3.59M	USD	Annual
Gain on disposal of property and equipment	`AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment`	$-94.00K	USD	Annual
Gain on disposal of property and equipment	`AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment`	$-74.00K	USD	Annual
Transaction cost related to issuance of financial liability	`TransactionCostsOnIssuanceOfFinancialLiabilities`	$210.00K	USD	Annual
Stock-based compensation	`AdjustmentsForSharebasedPayments`	$171.00K	USD	Annual
Stock-based compensation	`AdjustmentsForSharebasedPayments`	$4.95M	USD	Annual
Bad debt expense	`AdjustmentsForProvisions`	$7.96M	USD	Annual
Bad debt expense	`AdjustmentsForProvisions`	$6.44M	USD	Annual
Change in inventory reserve	`AdjustmentsForChangeInInventoryReserve`	$-45.00K	USD	Annual
Change in inventory reserve	`AdjustmentsForChangeInInventoryReserve`	$-31.00K	USD	Annual
Government grant	`AdjustmentsForGovernmentGrant`	$-1.17M	USD	Annual
Deferred income taxes	`AdjustmentsForIncomeTaxExpense`	$-3.80M	USD	Annual
Net increase in accounts receivable	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-5.12M	USD	Annual
Net increase in accounts receivable	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-8.82M	USD	Annual
Net increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-1.73M	USD	Annual
Net increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-44.00K	USD	Annual
Net increase in prepaid and other current assets	`AdjustmentsForDecreaseIncreaseInPrepaidAndOtherCurrentAssets`	$-858.00K	USD	Annual
Net increase in prepaid and other current assets	`AdjustmentsForDecreaseIncreaseInPrepaidAndOtherCurrentAssets`	$115.00K	USD	Annual
Net decrease in deferred revenue	`AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities`	$333.00K	USD	Annual
Net decrease in deferred revenue	`AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities`	$366.00K	USD	Annual
Net increase in accounts payables and accrued liabilities	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$1.75M	USD	Annual
Net increase in accounts payables and accrued liabilities	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$518.00K	USD	Annual
Net cash flow provided by operating activities	`CashFlowsFromUsedInOperatingActivities`	$14.03M	USD	Annual
Net cash flow provided by operating activities	`CashFlowsFromUsedInOperatingActivities`	$18.69M	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$5.05M	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$91.00K	USD	Annual
Cash proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$253.00K	USD	Annual
Cash proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$98.00K	USD	Annual
Cash paid for acquisitions	`CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities`	$8.02M	USD	Annual
Cash paid for acquisitions	`CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities`	$12.89M	USD	Annual
Net cash flow used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-17.84M	USD	Annual
Net cash flow used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-7.85M	USD	Annual
Repayments of long-term debt	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	$13.89M	USD	Annual
Repayments of long-term debt	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	$12.97M	USD	Annual
Payments of purchase price payable	`ConsiderationPaidReceived`	$1.27M	USD	Annual
Issuance costs relating to revolving credit facility	`IssuanceCostOfRevolvingCreditFacility`	$571.00K	USD	Annual
Proceeds from government grant	`ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities`	$6.01M	USD	Annual
Proceeds from exercise of warrants	`IfrsProceedsFromWarrantExercises`	$1.64M	USD	Annual
Proceeds from exercise of warrants	`IfrsProceedsFromWarrantExercises`	$17.47M	USD	Annual
Proceeds from issuance of common shares	`ProceedsFromIssueOfOrdinaryShares`	$19.19M	USD	Annual
Proceeds from exercise of options	`ProceedsFromExerciseOfOptions`	$1.60M	USD	Annual
Proceeds from exercise of options	`ProceedsFromExerciseOfOptions`	$424.00K	USD	Annual
Net cash flow provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$13.72M	USD	Annual
Net cash flow provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$3.91M	USD	Annual
Net increase in cash	`IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges`	$4.76M	USD	Annual
Net increase in cash	`IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges`	$19.90M	USD	Annual
Effect of exchange rate changes on cash held in foreign currencies	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$-383.00K	USD	Annual
Effect of exchange rate changes on cash held in foreign currencies	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$621.00K	USD	Annual
Cash, beginning of year	`CashAndCashEquivalents`	$29.23M	USD	Point-in-time
Cash, beginning of year	`CashAndCashEquivalents`	$9.71M	USD	Point-in-time
Cash, beginning of year	`CashAndCashEquivalents`	$34.61M	USD	Point-in-time
Cash, end of year	`CashAndCashEquivalents`	$29.23M	USD	Point-in-time
Cash, end of year	`CashAndCashEquivalents`	$9.71M	USD	Point-in-time
Cash, end of year	`CashAndCashEquivalents`	$34.61M	USD	Point-in-time

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Transaction costs	`ShareIssueRelatedCost`	$2.65M	USD	Annual
Transfer of derivative warrant liability	`DerivativeWarrantLiabilityTransferred`	$4.14M	USD	Annual
Balance at beginning of period	`Equity`	$58.62M	USD	Point-in-time
Balance at beginning of period	`Equity`	$13.02M	USD	Point-in-time
Balance at beginning of period	`Equity`	$28.23M	USD	Point-in-time
Net loss	`ProfitLoss`	$-6.17M	USD	Annual
Net loss	`ProfitLoss`	$-4.57M	USD	Annual
Stock-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$4.95M	USD	Annual
Stock-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$171.00K	USD	Annual
Proceeds from shares issued in bought deal, net of transaction costs	`IssueOfEquity`	$19.19M	USD	Annual
Stock options exercised	`IncreaseDecreaseThroughExerciseOfOptions`	$201.00K	USD	Annual
Stock options exercised	`IncreaseDecreaseThroughExerciseOfOptions`	$209.00K	USD	Annual
Stock to be issued from acquisition	`IncreaseDecreaseThroughSharesToBeIssuedFromAcquisitionEquity`	$3.03M	USD	Annual
Conversion of debentures	`IncreaseDecreaseThroughConversionOfConvertibleInstruments`	$5.36M	USD	Annual
Compensation options exercised	`IncreaseDecreaseThroughExerciseOfCompensationOptionsEquity`	$1.40M	USD	Annual
Compensation options exercised	`IncreaseDecreaseThroughExerciseOfCompensationOptionsEquity`	$215.00K	USD	Annual
Exercise of warrants, including transfer of derivative warrant liability	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	$21.61M	USD	Annual
Balance at end of period	`Equity`	$58.62M	USD	Point-in-time
Balance at end of period	`Equity`	$13.02M	USD	Point-in-time
Balance at end of period	`Equity`	$28.23M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.